institutional access

You are connecting from
Lake Geneva Public Library,
please login or register to take advantage of your institution's Ground News Plan.

Published loading...Updated

NHS told to help fat jab users keep weight off

UNITED KINGDOM, AUG 4 – Demand for weight loss jabs has surged 1,300% in private clinics as NHS eligibility remains strict, with plans to treat 220,000 patients over three years in England.

  • The NHS has been recommended to monitor patients for at least a year after they finish treatments such as Wegovy and Mounjaro to help prevent them from regaining lost weight.
  • This guidance follows evidence from drug trials showing patients regain about two-thirds of their weight after stopping injections and highlights the long-term nature of weight management.
  • Wegovy is available on the NHS for individuals with significant health issues related to their weight, prescribed for up to a two-year period. Over the next three years, it is anticipated that Mounjaro will be provided to approximately 240,000 eligible patients based on their BMI and associated health conditions.
  • Jonathan Benger from NICE stated that successful weight management continues after medication stops, requiring structured support to maintain positive changes, while Kamila Hawthorn emphasized there is no one-size-fits-all approach to obesity treatment.
  • These developments suggest a shift toward combining medication with lifestyle changes and ongoing support, implying the NHS must enhance prevention and post-treatment care to effectively combat obesity.
Insights by Ground AI
Does this summary seem wrong?

4 Articles

Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • 67% of the sources are Center
67% Center

Factuality 

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

iNews broke the news in London, United Kingdom on Monday, August 4, 2025.
Sources are mostly out of (0)